Structural Analysis Implicates CASK-Liprin-α2 Interaction in Cerebellar Granular Cell Death in MICPCH Syndrome.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 04 2023
Historique:
received: 11 11 2022
revised: 06 04 2023
accepted: 10 04 2023
medline: 17 5 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Microcephaly with pontine and cerebellar hypoplasia (MICPCH) syndrome is a neurodevelopmental disorder caused by the deficiency of the X-chromosomal gene CASK. However, the molecular mechanisms by which CASK deficiency causes cerebellar hypoplasia in this syndrome remain elusive. In this study, we used CASK knockout (KO) mice as models for MICPCH syndrome and investigated the effect of CASK mutants. Female CASK heterozygote KO mice replicate the progressive cerebellar hypoplasia observed in MICPCH syndrome. CASK KO cultured cerebellar granule (CG) cells show progressive cell death that can be rescued by co-infection with lentivirus expressing wild-type CASK. Rescue experiments with CASK deletion mutants identify that the CaMK, PDZ, and SH3, but not L27 and guanylate kinase domains of CASK are required for the survival of CG cells. We identify missense mutations in the CaMK domain of CASK derived from human patients that fail to rescue the cell death of cultured CASK KO CG cells. Machine learning-based structural analysis using AlphaFold 2.2 predicts that these mutations disrupt the structure of the binding interface with Liprin-α2. These results suggest that the interaction with Liprin-α2 via the CaMK domain of CASK may be involved in the pathophysiology of cerebellar hypoplasia in MICPCH syndrome.

Identifiants

pubmed: 37190086
pii: cells12081177
doi: 10.3390/cells12081177
pmc: PMC10136522
pii:
doi:

Substances chimiques

CASK kinases EC 2.7.11.1
Guanylate Kinases EC 2.7.4.8
PPFIA2 protein, human 0
Membrane Proteins 0
Adaptor Proteins, Signal Transducing 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2002 Aug 30;297(5586):1525-31
pubmed: 12202822
Am J Med Genet A. 2012 Dec;158A(12):3112-8
pubmed: 23165780
Nature. 2000 Mar 16;404(6775):298-302
pubmed: 10749215
J Neurosci. 2002 Jun 1;22(11):4264-73
pubmed: 12040031
Genomics. 1998 Jul 15;51(2):308-9
pubmed: 9722958
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
J Mol Biol. 2011 Sep 9;412(1):3-13
pubmed: 21763699
Genomics. 2002 Jun;79(6):849-59
pubmed: 12036300
J Med Genet. 2011 Nov;48(11):741-51
pubmed: 21954287
Orphanet J Rare Dis. 2015 Apr 12;10:44
pubmed: 25886057
J Neurosci. 1996 Apr 15;16(8):2488-94
pubmed: 8786425
Nat Genet. 2008 Sep;40(9):1065-7
pubmed: 19165920
J Neurosci. 1999 Sep 1;19(17):7415-25
pubmed: 10460248
J Cell Biol. 1998 Jul 13;142(1):139-51
pubmed: 9660869
Ital J Pediatr. 2022 May 12;48(1):73
pubmed: 35550617
Am J Hum Genet. 2009 Feb;84(2):162-77
pubmed: 19200522
Neuron. 2004 Apr 8;42(1):113-28
pubmed: 15066269
Neurosci Res. 2018 Feb;127:53-60
pubmed: 29221905
Cell. 2008 Apr 18;133(2):328-39
pubmed: 18423203
Cell Rep. 2022 Apr 5;39(1):110624
pubmed: 35385735
Ann Neurol. 2009 Oct;66(4):438-43
pubmed: 19847910
Orphanet J Rare Dis. 2012 Mar 27;7:18
pubmed: 22452838
J Cell Biol. 2005 Sep 26;170(7):1127-34
pubmed: 16186258
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):E1291-9
pubmed: 24639501
Cell. 1998 Sep 18;94(6):773-82
pubmed: 9753324
J Psychiatry Neurosci. 2017 Jan;42(1):37-47
pubmed: 28234597
Life Sci Alliance. 2022 Sep 22;5(10):
pubmed: 36137748
Mol Psychiatry. 2019 Jul;24(7):1079-1092
pubmed: 30610199
Cells. 2022 Mar 28;11(7):
pubmed: 35406695
Nat Genet. 2009 May;41(5):535-43
pubmed: 19377476
Am J Med Genet A. 2019 Jan;179(1):94-103
pubmed: 30549415
Acta Neuropathol Commun. 2016 Mar 31;4:30
pubmed: 27036546
PLoS One. 2017 Aug 7;12(8):e0181791
pubmed: 28783747
Cells. 2021 Oct 12;10(10):
pubmed: 34685703
Intractable Rare Dis Res. 2017 Aug;6(3):177-182
pubmed: 28944139
Eur J Hum Genet. 2010 May;18(5):544-52
pubmed: 20029458
Structure. 2020 Jun 2;28(6):664-673.e3
pubmed: 32348748
J Neurochem. 2021 May;157(4):1331-1350
pubmed: 33090494
Hum Mutat. 2018 Jul;39(7):993-1001
pubmed: 29691940
Hum Genet. 2018 Mar;137(3):231-246
pubmed: 29426960
Neurosci Res. 2017 Mar;116:3-9
pubmed: 27664583
Mol Cell. 2011 Aug 19;43(4):586-98
pubmed: 21855798
J Neurochem. 2004 Dec;91(6):1483-92
pubmed: 15584924
Cell Mol Life Sci. 2016 Sep;73(18):3599-621
pubmed: 27015872
J Med Genet. 2022 Nov;59(11):1044-1057
pubmed: 35149592
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2525-30
pubmed: 17287346
J Physiol. 1988 Jun;400:189-222
pubmed: 2458453

Auteurs

Qi Guo (Q)

Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Emi Kouyama-Suzuki (E)

Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Yoshinori Shirai (Y)

Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.

Xueshan Cao (X)

College of Life Science and Oceanography, Shenzhen University, Shenzhen 518071, China.

Toru Yanagawa (T)

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

Takuma Mori (T)

Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Department of NeuroHealth Innovation, Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto 390-8621, Japan.

Katsuhiko Tabuchi (K)

Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Department of NeuroHealth Innovation, Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto 390-8621, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH